Page
Oncology
According to the World Health Organization (WHO), in 2020 cancer accounted for nearly 10 million deaths worldwide – that’s almost one in every six deaths – with cancers of the lung, colon, and rectum, and prostate being the most common.

Article
Talking Images podcast: The sustainable way – voices of action
Talking Images podcast: The sustainable way – voices of action. What do environmental sustainability and sustainable future mean?

Product
ProHance
ProHance® (gadoteridol) is a macrocyclic, non-ionic molecule chelated to a gadolinium ion, and it has a very low osmolality and viscosity 5

Product
Iomeron
Iomeron® is a tri-iodinated non-ionic monomeric contrast medium for radiology 7
An injectable solution at a higher iodine concentration allows a greater peak of enhancement in a shorter time from the injection when injected at the same volume and flow rate compared to a solution at a lower iodine concentration 8.

Product
Empower CTA+
Efficiency and Control at your fingertips
The Empower CTA+ Injector System is the robust and intuitive syringe-based injector for CT imaging by Bracco, re-engineered in order to ensure operational efficiencies and patient safety.

Product
Multihance
MultiHance® (gadobenate dimeglumine) is a gadolinium-based contrast agent (GBCA) currently approved in the European Union, Norway and Iceland for use in diagnostic magnetic resonance imaging (MRI) of the liver in adult and in pediatric patients older than two years of age.1

Product
Empower MR
The EmpowerMR® Contrast Injection System is a state-of-the-art integrated contrast injection system designed to meet the demands of today's advanced MR procedures.

Product
Sonovue
SonoVue® is a second-generation ultrasound contrast agent designed and optimized with regard to the resistance to pressure.

Product
VueBox
VueBoxTM is a general-purpose software application for quantifying tissue perfusion using Dynamic Contrast-Enhanced Ultrasound (DCE-US).

Product
ACIST CVi
CVi delivers the power to improve patient safety, minimizing the risk of CI-AKI for coronary catheterizations when compared to manual injection of contrast media.
